Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 6/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
PHA Stock Overview
Pharmagest Interactive SA provides various IT solutions for the healthcare sector in Europe.
Rewards
Risk Analysis
No risks detected for PHA from our risk checks.
Pharmagest Interactive Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €80.70 |
52 Week High | €103.00 |
52 Week Low | €67.00 |
Beta | 0.94 |
1 Month Change | 0.50% |
3 Month Change | 13.34% |
1 Year Change | -12.19% |
3 Year Change | 48.07% |
5 Year Change | 95.64% |
Change since IPO | 1,794.37% |
Recent News & Updates
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Shareholder Returns
PHA | FR Healthcare Services | FR Market | |
---|---|---|---|
7D | 4.4% | 4.4% | -1.3% |
1Y | -12.2% | -12.0% | -5.4% |
Return vs Industry: PHA matched the French Healthcare Services industry which returned -12% over the past year.
Return vs Market: PHA underperformed the French Market which returned -5.4% over the past year.
Price Volatility
PHA volatility | |
---|---|
PHA Average Weekly Movement | 3.8% |
Healthcare Services Industry Average Movement | 7.5% |
Market Average Movement | 6.1% |
10% most volatile stocks in FR Market | 10.4% |
10% least volatile stocks in FR Market | 3.6% |
Stable Share Price: PHA is less volatile than 75% of French stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: PHA's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 1,100 | Denis Supplisson | https://pharmagest.com |
Pharmagest Interactive SA provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists’ business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services.
Pharmagest Interactive Fundamentals Summary
PHA fundamental statistics | |
---|---|
Market Cap | €1.21b |
Earnings (TTM) | €34.67m |
Revenue (TTM) | €187.72m |
35.0x
P/E Ratio6.5x
P/S RatioIs PHA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHA income statement (TTM) | |
---|---|
Revenue | €187.72m |
Cost of Revenue | €124.69m |
Gross Profit | €63.04m |
Other Expenses | €28.37m |
Earnings | €34.67m |
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Sep 23, 2022
Earnings per share (EPS) | 2.31 |
Gross Margin | 33.58% |
Net Profit Margin | 18.47% |
Debt/Equity Ratio | 42.0% |
How did PHA perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield41%
Payout RatioValuation
Is Pharmagest Interactive undervalued compared to its fair value and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
16.6%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PHA (€80.7) is trading below our estimate of fair value (€96.72)
Significantly Below Fair Value: PHA is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: PHA's PE Ratio (35x) is in line with the European Healthcare Services industry average.
PE vs Market: PHA is poor value based on its PE Ratio (35x) compared to the French market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: PHA is poor value based on its PEG Ratio (2.4x)
Price to Book Ratio
PB vs Industry: PHA is overvalued based on its PB Ratio (8.8x) compared to the FR Healthcare Services industry average (2.6x).
Future Growth
How is Pharmagest Interactive forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score
4/6Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
14.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHA's forecast earnings growth (14.6% per year) is above the savings rate (0.3%).
Earnings vs Market: PHA's earnings (14.6% per year) are forecast to grow faster than the French market (12% per year).
High Growth Earnings: PHA's earnings are forecast to grow, but not significantly.
Revenue vs Market: PHA's revenue (9.6% per year) is forecast to grow faster than the French market (5.8% per year).
High Growth Revenue: PHA's revenue (9.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PHA's Return on Equity is forecast to be high in 3 years time (21.9%)
Past Performance
How has Pharmagest Interactive performed over the past 5 years?
Past Performance Score
6/6Past Performance Score 6/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
10.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PHA has high quality earnings.
Growing Profit Margin: PHA's current net profit margins (18.5%) are higher than last year (17.1%).
Past Earnings Growth Analysis
Earnings Trend: PHA's earnings have grown by 10.2% per year over the past 5 years.
Accelerating Growth: PHA's earnings growth over the past year (26.7%) exceeds its 5-year average (10.2% per year).
Earnings vs Industry: PHA earnings growth over the past year (26.7%) exceeded the Healthcare Services industry -3%.
Return on Equity
High ROE: PHA's Return on Equity (25.8%) is considered high.
Financial Health
How is Pharmagest Interactive's financial position?
Financial Health Score
5/6Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: PHA's short term assets (€116.1M) exceed its short term liabilities (€99.9M).
Long Term Liabilities: PHA's short term assets (€116.1M) exceed its long term liabilities (€60.2M).
Debt to Equity History and Analysis
Debt Level: PHA has more cash than its total debt.
Reducing Debt: PHA's debt to equity ratio has increased from 5.4% to 42% over the past 5 years.
Debt Coverage: PHA's debt is well covered by operating cash flow (90.7%).
Interest Coverage: PHA earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Pharmagest Interactive current dividend yield, its reliability and sustainability?
Dividend Score
4/6Dividend Score 4/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
1.18%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PHA's dividend (1.18%) isn’t notable compared to the bottom 25% of dividend payers in the French market (1.72%).
High Dividend: PHA's dividend (1.18%) is low compared to the top 25% of dividend payers in the French market (5%).
Stability and Growth of Payments
Stable Dividend: PHA's dividends per share have been stable in the past 10 years.
Growing Dividend: PHA's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (41.2%), PHA's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate cash payout ratio to determine if its dividend payments are covered by cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
1.8yrs
Average management tenure
CEO
Denis Supplisson (52 yo)
0.083
Tenure
€370,876
Compensation
Mr. Denis Supplisson serves as Chief Executive Officer at Pharmagest Interactive SA since April 22, 2022. He served as Deputy Managing Director/Deputy Chief Executive Officer & Manager of the Europe Pharma...
CEO Compensation Analysis
Compensation vs Market: Denis's total compensation ($USD391.26K) is below average for companies of similar size in the French market ($USD921.08K).
Compensation vs Earnings: Denis's compensation has increased by more than 20% in the past year.
Leadership Team
Experienced Management: PHA's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
Experienced Board: PHA's board of directors are seasoned and experienced ( 11.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Pharmagest Interactive SA's employee growth, exchange listings and data sources
Key Information
- Name: Pharmagest Interactive SA
- Ticker: PHA
- Exchange: ENXTPA
- Founded: 1996
- Industry: Health Care Technology
- Sector: Healthcare
- Implied Market Cap: €1.212b
- Shares outstanding: 15.02m
- Website: https://pharmagest.com
Number of Employees
Location
- Pharmagest Interactive SA
- 5 AllEe de Saint Cloud
- BP 117
- Villers-lès-Nancy
- Lorraine
- 54601
- France
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/05/22 00:00 |
End of Day Share Price | 2022/05/20 00:00 |
Earnings | 2021/06/30 |
Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.